Fluoropyrimidines in cancer therapy /
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[2003]
|
| Series: | Cancer drug discovery and development.
|
| Subjects: |
Table of Contents:
- Relative role of 5-fluorouracil activation and inactivation pathways on its cytotoxic effects : preclinical and clinical modulation
- Dihydropyrimidines : past and future directions
- Biochemical bases of the 5-fluorouracil-folinic acid interaction and of its limitations : a retrospective analysis
- Molecular mechanisms regulating the expression of thymidylate synthase
- Regulation of thymidylate synthase gene expression and drug response : posttranscriptional regulation and cell population density
- Death receptor signaling in the mechanism of 5-fluorouracil action
- Circadian rhythms in 5-fluorouracil pharmacology and therapeutic applications
- Relevance of scheduling to the efficacy of 5-fluorouracil alone and in combination with other agents
- Noninvasive studies of fluoropyrimidines
- Comparative antitumor activity of 5-fluorouracil (5-FU) prodrugs in preclinical model systems : role of leucovorin and dihydropyrimidine dehydrogenase inhibitors
- Bimonthly 48-h leucovorin and 5-fluorouracil-based regimens in advanced colorectal cancer
- Review on the combination of systemic and locoregional treatment for colorectal liver metastases
- Fluoropyrimidines in advanced colorectal cancer : a review of six consecutive meta-analyses
- The Mayo/NCCTG experience with 5-fluorouracil and leucovorin in adjuvant advanced colorectal cancer
- Fluoropyrimidines for the adjuvant treatment of colorectal cancer : the NSABP experience
- Clinical trials of UFT leucovorin in gastrointestinal malignancies
- The development of oral UFT with and without leucovorin
- UFT in elderly patients with colorectal cancer
- Clinical trials of the eniluracil/5-fluorouracil combination
- Discovery and preclinical pharmacology of capecitabine
- Capecitabine, a tumor-targeting oral fluoropyrimidine : molecular rationale and clinical validation
- Capecitabine : a rationally developed anticancer drug
- Preclinical and clinical practice of S-1 in Japan
- Preclinical and clinical practice of low-dose FP therapy in Japan : Japanese use of low-dose FP therapy